Haleon plc (HLN) Financial Statements
Price: $9.89
Market Cap: $44.77B
Avg Volume: 10.65M
Market Cap: $44.77B
Avg Volume: 10.65M
Country: GB
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Haleon plc.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Revenue | $11.23B | $11.30B | $10.86B | $9.54B | $9.89B | $8.48B |
| Cost of Revenue | $4.29B | $4.34B | $4.28B | $3.60B | $3.98B | $3.68B |
| Gross Profit | $6.95B | $6.96B | $6.58B | $5.95B | $5.91B | $4.80B |
| Gross Profit Ratio | 61.85% | 61.59% | 60.57% | 62.34% | 59.75% | 56.63% |
| Research and Development Expenses | $298.00M | $311.00M | $300.00M | $257.00M | $304.00M | $292.00M |
| General and Administrative Expenses | $4.45B | $2.27B | $4.48B | $4.09B | $4.22B | $3.60B |
| Selling and Marketing Expenses | $-119.00M | $2.02B | $2.03B | $1.94B | $- | $- |
| Selling General and Administrative Expenses | $4.33B | $4.29B | $4.48B | $4.09B | $4.22B | $3.60B |
| Other Expenses | $111.00M | $366.00M | $-31.00M | $-31.00M | $-212.00M | $17.00M |
| Operating Expenses | $4.74B | $4.96B | $4.75B | $4.31B | $4.31B | $3.90B |
| Cost and Expenses | $9.03B | $9.31B | $9.03B | $7.91B | $8.29B | $7.58B |
| Interest Income | $65.00M | $14.00M | $51.00M | $17.00M | $14.00M | $24.00M |
| Interest Expense | $394.00M | $414.00M | $258.00M | $12.00M | $15.00M | $26.00M |
| Depreciation and Amortization | $196.00M | $309.00M | $287.00M | $268.00M | $305.00M | $260.00M |
| EBITDA | $2.51B | $2.35B | $2.18B | $2.21B | $1.91B | $1.17B |
| EBITDA Ratio | 22.38% | 20.80% | 20.10% | 23.16% | 19.32% | 13.82% |
| Operating Income | $2.21B | $2.00B | $1.82B | $1.64B | $1.60B | $897.00M |
| Operating Income Ratio | 19.64% | 17.66% | 16.81% | 17.16% | 16.15% | 10.58% |
| Total Other Income Expenses Net | $-296.00M | $-368.00M | $-207.00M | $-2.00M | $-7.00M | $-11.00M |
| Income Before Tax | $1.91B | $1.63B | $1.62B | $1.64B | $1.59B | $886.00M |
| Income Before Tax Ratio | 17.00% | 14.40% | 14.90% | 17.14% | 16.08% | 10.45% |
| Income Tax Expense | $435.00M | $517.00M | $499.00M | $197.00M | $410.00M | $199.00M |
| Net Income | $1.44B | $1.05B | $1.06B | $1.39B | $1.15B | $655.00M |
| Net Income Ratio | 12.84% | 9.28% | 9.76% | 14.56% | 11.58% | 7.72% |
| EPS | $0.16 | $0.11 | $0.11 | $0.15 | $0.12 | $0.07 |
| EPS Diluted | $0.16 | $0.11 | $0.11 | $0.15 | $0.12 | $0.07 |
| Weighted Average Shares Outstanding | 9.18B | 9.26B | 9.23B | 9.23B | 9.23B | 9.23B |
| Weighted Average Shares Outstanding Diluted | 9.18B | 9.26B | 9.24B | 9.23B | 9.23B | 9.23B |
| SEC Filing | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $2.25B | $1.04B | $684.00M | $414.00M | $334.00M | $340.00M |
| Short Term Investments | $- | $- | $- | $1.00M | $1.00M | $1.00M |
| Cash and Short Term Investments | $2.25B | $1.04B | $684.00M | $414.00M | $334.00M | $340.00M |
| Net Receivables | $2.06B | $1.35B | $1.49B | $3.83B | $3.59B | $3.99B |
| Inventory | $1.19B | $1.41B | $1.35B | $951.00M | $949.00M | $1.21B |
| Other Current Assets | $223.00M | $1.01B | $540.00M | $2.57B | $2.38B | $2.86B |
| Total Current Assets | $5.72B | $4.82B | $4.06B | $5.25B | $5.01B | $5.81B |
| Property Plant Equipment Net | $1.92B | $1.90B | $1.90B | $1.66B | $1.60B | $1.62B |
| Goodwill | $- | $8.32B | $8.40B | $8.25B | $8.27B | $8.17B |
| Intangible Assets | $26.21B | $18.54B | $20.04B | $18.95B | $18.95B | $19.84B |
| Goodwill and Intangible Assets | $26.21B | $26.86B | $28.44B | $27.20B | $27.22B | $28.01B |
| Long Term Investments | $82.00M | $65.00M | $44.00M | $23.00M | $41.00M | $3.00M |
| Tax Assets | $- | $- | $220.00M | $312.00M | $251.00M | $254.00M |
| Other Non-Current Assets | $383.00M | $415.00M | $157.00M | $8.00M | $10.00M | $10.00M |
| Total Non-Current Assets | $28.60B | $29.24B | $30.76B | $29.20B | $29.12B | $29.90B |
| Other Assets | $- | $- | $- | $- | $- | $- |
| Total Assets | $34.31B | $34.05B | $34.81B | $34.45B | $34.13B | $35.71B |
| Account Payables | $1.97B | $1.85B | $1.83B | $1.58B | $1.83B | $1.90B |
| Short Term Debt | $1.58B | $656.00M | $437.00M | $922.00M | $382.00M | $521.00M |
| Tax Payables | $286.00M | $288.00M | $210.00M | $237.00M | $278.00M | $226.00M |
| Deferred Revenue | $- | $- | $23.00M | $11.00M | $11.00M | $7.00M |
| Other Current Liabilities | $1.98B | $1.84B | $1.89B | $1.50B | $1.53B | $1.62B |
| Total Current Liabilities | $5.81B | $4.64B | $4.37B | $4.24B | $4.01B | $4.27B |
| Long Term Debt | $8.71B | $8.80B | $10.18B | $88.00M | $105.00M | $121.00M |
| Deferred Revenue Non-Current | $- | $- | $- | $281.00M | $401.00M | $374.00M |
| Deferred Tax Liabilities Non-Current | $- | $- | $3.60B | $3.36B | $3.37B | $3.51B |
| Other Non-Current Liabilities | $3.57B | $3.89B | $3.81B | $3.36B | $3.39B | $3.54B |
| Total Non-Current Liabilities | $12.28B | $12.69B | $13.99B | $3.73B | $3.89B | $4.03B |
| Other Liabilities | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $18.09B | $17.33B | $18.36B | $7.97B | $7.91B | $8.30B |
| Preferred Stock | $- | $- | $- | $- | $- | $- |
| Common Stock | $91.00M | $92.00M | $92.00M | $1.00M | $1.00M | $1.00M |
| Retained Earnings | $27.27B | $27.47B | $26.73B | $37.99B | $37.76B | $5.11B |
| Accumulated Other Comprehensive Income Loss | $- | $- | $1.20B | $-11.63B | $-11.65B | $1.37B |
| Other Total Stockholders Equity | $-11.20B | $-10.96B | $-11.69B | $-448.00M | $- | $20.84B |
| Total Stockholders Equity | $16.17B | $16.61B | $16.33B | $26.36B | $26.11B | $27.32B |
| Total Equity | $16.22B | $16.73B | $16.46B | $26.48B | $26.22B | $27.41B |
| Total Liabilities and Stockholders Equity | $34.31B | $34.05B | $34.81B | $34.45B | $34.13B | $35.71B |
| Minority Interest | $58.00M | $123.00M | $126.00M | $125.00M | $111.00M | $91.00M |
| Total Liabilities and Total Equity | $34.31B | $34.05B | $34.81B | $34.45B | $34.13B | $35.71B |
| Total Investments | $82.00M | $65.00M | $44.00M | $1.00M | $1.00M | $1.00M |
| Total Debt | $10.29B | $9.46B | $10.44B | $991.00M | $487.00M | $642.00M |
| Net Debt | $8.04B | $8.41B | $9.76B | $577.00M | $153.00M | $302.00M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 |
|---|---|---|---|---|---|---|
| Net Income | $1.44B | $1.11B | $1.12B | $1.44B | $1.18B | $687.00M |
| Depreciation and Amortization | $324.00M | $309.00M | $287.00M | $268.00M | $305.00M | $260.00M |
| Deferred Income Tax | $- | $- | $62.00M | $197.00M | $410.00M | $199.00M |
| Stock Based Compensation | $102.00M | $76.00M | $15.00M | $59.00M | $63.00M | $58.00M |
| Change in Working Capital | $48.00M | $-107.00M | $181.00M | $-152.00M | $15.00M | $-461.00M |
| Accounts Receivables | $-312.00M | $38.00M | $-85.00M | $14.00M | $18.00M | $-57.00M |
| Inventory | $216.00M | $-131.00M | $-292.00M | $-17.00M | $130.00M | $232.00M |
| Accounts Payables | $- | $112.00M | $387.00M | $41.00M | $140.00M | $-256.00M |
| Other Working Capital | $144.00M | $-126.00M | $171.00M | $-190.00M | $-273.00M | $-380.00M |
| Other Non Cash Items | $385.00M | $711.00M | $353.00M | $-20.00M | $198.00M | $362.00M |
| Net Cash Provided by Operating Activities | $2.30B | $2.10B | $2.06B | $1.36B | $1.41B | $786.00M |
| Investments in Property Plant and Equipment | $-250.00M | $-234.00M | $-328.00M | $-298.00M | $-318.00M | $-243.00M |
| Acquisitions Net | $- | $-71.00M | $9.21B | $112.00M | $241.00M | $120.00M |
| Purchases of Investments | $- | $- | $-9.21B | $-112.00M | $96.00M | $53.00M |
| Sales Maturities of Investments | $- | $- | $700.00M | $100.00M | $158.00M | $219.00M |
| Other Investing Activities | $778.00M | $171.00M | $-9.16B | $165.00M | $853.00M | $142.00M |
| Net Cash Used for Investing Activities | $528.00M | $-134.00M | $-8.78B | $-33.00M | $1.03B | $291.00M |
| Debt Repayment | $592.00M | $-553.00M | $9.49B | $8.00M | $28.00M | $1.00M |
| Common Stock Issued | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $-121.00M | $-38.00M | $- | $- | $- | $- |
| Dividends Paid | $-570.00M | $-388.00M | $-2.68B | $-1.15B | $-2.37B | $-1.15B |
| Other Financing Activities | $-1.44B | $-627.00M | $107.00M | $-96.00M | $-94.00M | $226.00M |
| Net Cash Used Provided by Financing Activities | $-1.54B | $-1.57B | $6.91B | $-1.24B | $-2.44B | $-925.00M |
| Effect of Forex Changes on Cash | $-79.00M | $-15.00M | $15.00M | $-5.00M | $-6.00M | $-14.00M |
| Net Change in Cash | $1.21B | $383.00M | $205.00M | $82.00M | $-6.00M | $138.00M |
| Cash at End of Period | $2.21B | $994.00M | $611.00M | $405.00M | $323.00M | $329.00M |
| Cash at Beginning of Period | $994.00M | $611.00M | $406.00M | $323.00M | $329.00M | $191.00M |
| Operating Cash Flow | $2.30B | $2.10B | $2.06B | $1.36B | $1.41B | $786.00M |
| Capital Expenditure | $-250.00M | $-336.00M | $-328.00M | $-298.00M | $-318.00M | $-243.00M |
| Free Cash Flow | $2.05B | $1.76B | $1.74B | $1.06B | $1.09B | $543.00M |